AIFarm, Ltd. (AIFM) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerAIFarm, Ltd. (AIFM) trades at $0.003. AIFarm, Ltd. is a development stage company specializing in custom biodome design and construction for commercial and local agricultural producers. Sector: Industrials.
Price as of · Last analyzed: Mar 18, 2026Analyst Coverage for AIFM: AIFM does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
AIFarm, Ltd. (AIFM) Industrial Operations Profile
AIFarm, Ltd. is a development stage company focused on designing and building custom biodomes for agricultural applications globally. Operating in the Agricultural-Machinery industry, AIFarm caters to both commercial and small-scale producers, offering tailored growing systems from its base in Hong Kong.
What Is the Investment Thesis for AIFM?
AIFarm, Ltd. presents a high-risk, high-reward investment opportunity given its development stage and focus on the emerging biodome market. The company's potential lies in its ability to capitalize on the growing demand for sustainable and efficient agricultural solutions. However, investors should be aware of the significant risks associated with investing in a development stage company, including limited operating history, reliance on future funding, and intense competition. The company's success hinges on its ability to secure funding, execute its business plan, and gain market share in the competitive agricultural technology landscape. With a market capitalization of $0.00B and negative P/E ratio, AIFarm's financial viability remains uncertain.
Based on FMP financials and quantitative analysis
AIFM Key Highlights
AIFarm, Ltd. is a development stage company specializing in biodome design and construction.
- The company targets both commercial and small local agricultural producers.
- AIFarm's proprietary growing system aims to optimize growing conditions for year-round crop production.
- The company changed its name from Eco Energy Tech Asia, Ltd. in January 2020.
- AIFarm is based in Kowloon, Hong Kong, and has a small team of 3 employees.
Who Are AIFM's Competitors?
AIFM is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| ARTW Art's-Way Manufacturing Co., Inc. | $3.13 | +4.16% | $16.3M | 41 5-pillar |
| XOS Xos, Inc. | $3.30 | +4.76% | $33.8M | — |
| RYM RYTHM, Inc. | $19.60 | -2.00% | $42.1M | — |
| GENC Gencor Industries, Inc. | $17.59 | +1.38% | $258M | 84 5-pillar |
| TWI Titan International Inc. | $6.99 | +2.79% | $451M | 36 5-pillar |
| CMCO Columbus McKinnon Corporation | $16.73 | +5.02% | $483M | — |
| HY Hyster-Yale Materials Handling, Inc. | $31.23 | +2.66% | $556M | 43 5-pillar |
| WNC Wabash National Corporation | $14.04 | +12.68% | $572M | 37 5-pillar |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are AIFM's Key Strengths?
Proprietary biodome design and construction expertise
- Customization capabilities to meet diverse client needs
- Focus on sustainable and efficient agricultural practices
- Potential to capitalize on the growing demand for CEA solutions
What Are AIFM's Weaknesses?
Development stage company with limited operating history
- Reliance on future funding to support growth
- Small team size and limited resources
- Lack of established brand recognition
What Are the Key Risks for AIFM?
Weak fundamentals — a Piotroski F-Score of 0/9 flags soft profitability, leverage or efficiency.
- Limited access to capital and funding.
- Intense competition from established players in the agricultural technology market.
- Economic downturns that could reduce demand for agricultural investments.
- Dependence on key personnel and expertise.
What Threats Does AIFM Face?
- Intense competition from established agricultural technology companies
- Economic downturns that could reduce demand for agricultural investments
- Changes in government regulations related to agriculture and environmental sustainability
- Technological advancements that could render AIFarm's solutions obsolete
What Are AIFM's Competitive Advantages?
- Proprietary growing system design
- Customization capabilities for diverse client needs
- Focus on sustainable and efficient agricultural practices
What Does AIFM Do?
Founded in 2012, AIFarm, Ltd., formerly known as Eco Energy Tech Asia, Ltd. until its name change in January 2020, is a development stage company specializing in the design and construction of custom biodomes. Headquartered in Kowloon, Hong Kong, AIFarm targets both commercial agricultural concerns and small local producers, offering a proprietary growing system tailored to their specific needs. The company's core business revolves around creating controlled environment agriculture (CEA) solutions through its biodomes, enabling year-round crop production, resource efficiency, and reduced environmental impact. AIFarm's biodomes are designed to optimize growing conditions, including temperature, humidity, and light, to maximize yields and minimize resource consumption. While still in the development stage, AIFarm aims to expand its global footprint by providing sustainable and efficient agricultural solutions to a diverse range of clients.
What Products and Services Does AIFM Offer?
- Designs and builds custom biodomes for agricultural purposes.
- Develops proprietary growing systems.
- Caters to commercial agricultural concerns.
- Serves small local producers.
- Offers controlled environment agriculture (CEA) solutions.
- Optimizes growing conditions within biodomes.
How Does AIFM Make Money?
- Generates revenue through the design and construction of custom biodomes.
- Offers proprietary growing systems tailored to client needs.
- Potentially generates revenue through ongoing support and maintenance services.
What Industry Does AIFM Operate In?
AIFarm, Ltd. operates within the agricultural machinery industry, which is experiencing increased demand for innovative and sustainable solutions. The global agricultural machinery market is projected to grow, driven by factors such as increasing population, rising food demand, and the need for efficient farming practices. Companies like AIFarm that offer specialized solutions such as biodomes are positioned to capitalize on this trend. However, the industry is also highly competitive, with established players and emerging startups vying for market share. AIFarm's success will depend on its ability to differentiate itself through technological innovation, cost-effectiveness, and strong customer relationships.
Who Are AIFM's Key Customers?
- Commercial agricultural businesses
- Small local agricultural producers
- Organizations seeking sustainable agriculture solutions
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Key Financial Metrics
Return on equity for AIFarm, Ltd. stands at 28.8%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.03 means current liabilities exceed short-term assets, a liquidity point worth watching.
Company Profile
AIFarm, Ltd. operates in the Agricultural - Machinery industry within the Industrials sector. It is headquartered in Hong Kong, HK. The company is led by CEO Yuen May Cheung. AIFM has traded publicly since 2016.
Financial Health
AIFarm, Ltd.'s Piotroski F-Score is 0/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
AIFM Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
AIFM Latest News
No recent news available for AIFM.
AIFM Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for AIFM.
Price Targets
Wall Street price target analysis for AIFM.
AIFM MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for AIFM; grades run from A+ (80-100) to F (below 30).
Leadership: Yuen May Cheung
Managing Director
Yuen May Cheung is the Managing Director of AIFarm, Ltd. and oversees the company's operations with a team of three employees. As the head of a development stage company, Cheung's role is critical in shaping the company's strategic direction and securing funding for future growth. Cheung's leadership will be instrumental in navigating the challenges and opportunities in the emerging biodome market.
Track Record: Due to AIFarm's status as a development stage company, there is limited information available regarding Yuen May Cheung's track record. Cheung's primary focus has been on establishing the company's foundation, developing its proprietary growing system, and securing initial clients. The success of AIFarm will depend on Cheung's ability to execute the company's business plan and achieve sustainable growth.
AIFM OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that AIFarm, Ltd. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be required to provide regular financial disclosures. Investing in companies on the OTC Other tier carries a higher degree of risk compared to those listed on major exchanges like the NYSE or NASDAQ due to the lack of regulatory oversight and transparency. Investors should conduct thorough due diligence before investing in OTC Other stocks.
- OTC Tier: OTC Other
- Limited financial disclosures and transparency
- Low trading volume and liquidity
- Higher risk of price manipulation
- Potential for delisting or suspension of trading
- Limited regulatory oversight
- Verify the company's registration and legal status
- Review available financial statements and disclosures
- Assess the company's business model and competitive landscape
- Evaluate the management team and their track record
- Understand the risks associated with investing in OTC stocks
- Consult with a financial advisor before making any investment decisions
- Company registration and legal compliance
- Existence of a website and contact information
- Press releases and media coverage
- Partnerships with reputable organizations
- Positive customer reviews or testimonials
AIFarm, Ltd. Industrials Stock: Key Questions Answered
What do analysts say about AIFM stock?
As of March 18, 2026, there are no readily available analyst ratings or price targets for AIFarm, Ltd. (AIFM). This is likely due to the company's status as a development stage company trading on the OTC market, which typically receives less analyst coverage than larger, exchange-listed companies.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is limited due to the company's development stage and OTC listing.
- Financial data is based on available information and may not be comprehensive.